SIVR vs. FMED
SIVR (abrdn Physical Silver Shares ETF) and FMED (Fidelity Disruptive Medicine ETF) are both exchange-traded funds - SIVR is a Silver fund tracking the LBMA Silver Price ($/ozt), while FMED is a Health & Biotech Equities fund actively managed by Fidelity. SIVR is passively managed, while FMED is actively managed. Over the past 3 years, SIVR returned 42.25%/yr vs 0.73%/yr for FMED. At a 0.19 correlation, their price movements are largely independent. SIVR charges 0.30%/yr vs 0.50%/yr for FMED.
Performance
SIVR vs. FMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SIVR achieves a -1.40% return, which is significantly higher than FMED's -4.75% return.
SIVR
- 1D
- 3.51%
- 1M
- -8.06%
- YTD
- -1.40%
- 6M
- 9.35%
- 1Y
- 92.86%
- 3Y*
- 42.25%
- 5Y*
- 20.46%
- 10Y*
- 14.57%
FMED
- 1D
- 0.90%
- 1M
- 7.10%
- YTD
- -4.75%
- 6M
- -6.17%
- 1Y
- 8.53%
- 3Y*
- 0.73%
- 5Y*
- —
- 10Y*
- —
SIVR vs. FMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
SIVR abrdn Physical Silver Shares ETF | -1.40% | 145.34% | 21.08% | -2.23% |
FMED Fidelity Disruptive Medicine ETF | -4.75% | 9.69% | 2.29% | -3.59% |
Correlation
The correlation between SIVR and FMED is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2023 | 0.19 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SIVR vs. FMED — Risk / Return Rank
SIVR
FMED
SIVR vs. FMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for abrdn Physical Silver Shares ETF (SIVR) and Fidelity Disruptive Medicine ETF (FMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SIVR | FMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.12 | ||
| Sortino ratioReturn per unit of downside risk | +1.06 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.09 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 2.06 | 0.47 | +1.59 |
| Martin ratioReturn relative to average drawdown | 4.44 | 1.03 | +3.40 |
Loading charts...
Drawdowns
SIVR vs. FMED - Drawdown Comparison
The maximum SIVR drawdown since its inception was -75.85%, which is greater than FMED's maximum drawdown of -21.84%. Use the drawdown chart below to compare losses from any high point for SIVR and FMED.
Loading charts...
Drawdown Indicators
| SIVR | FMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -75.85% | -21.84% | -54.01% |
Max Drawdown (1Y)Largest decline over 1 year | -45.33% | -18.33% | -27.00% |
Max Drawdown (3Y)Largest decline over 3 years | -45.33% | -21.84% | -23.49% |
Max Drawdown (5Y)Largest decline over 5 years | -45.33% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -45.33% | — | — |
Current DrawdownCurrent decline from peak | -39.85% | -10.64% | -29.21% |
Average DrawdownAverage peak-to-trough decline | -47.83% | -7.09% | -40.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.00% | 8.27% | +12.73% |
Volatility
SIVR vs. FMED - Volatility Comparison
abrdn Physical Silver Shares ETF (SIVR) has a higher volatility of 16.52% compared to Fidelity Disruptive Medicine ETF (FMED) at 7.50%. This indicates that SIVR's price experiences larger fluctuations and is considered to be riskier than FMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SIVR | FMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.52% | 7.50% | +9.02% |
Volatility (6M)Calculated over the trailing 6-month period | 59.14% | 15.01% | +44.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 59.96% | 19.37% | +40.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.53% | 18.57% | +17.96% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.05% | 18.57% | +13.48% |
SIVR vs. FMED - Expense Ratio Comparison
SIVR has a 0.30% expense ratio, which is lower than FMED's 0.50% expense ratio.
Dividends
SIVR vs. FMED - Dividend Comparison
Neither SIVR nor FMED has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.46% |
SIVR abrdn Physical Silver Shares ETF | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
SIVR and FMED have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SIVR has higher volatility (16.52%) compared to FMED (7.50%). In terms of maximum drawdown, SIVR dropped -75.85% vs FMED's -21.84%.
On 3-year performance, SIVR leads with 42.25% vs 0.73% for FMED. On fees, SIVR is cheaper at 0.30% per year. On volatility, FMED has been the lower-risk option at 7.50%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, SIVR has performed better with a 42.25% return vs 0.73%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SIVR is cheaper with a 0.30% expense ratio, compared with 0.50% for FMED.
SIVR and FMED have nearly identical dividend yields, around 0.00%.
SIVR is categorized as Silver, while FMED is Health & Biotech Equities. They also come from different issuers: abrdn and Fidelity. Their fees differ too: 0.30% for SIVR and 0.50% for FMED.
SIVR currently has the higher Sharpe Ratio (1.56 vs 0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SIVR and FMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer